Alan Moses is listed as a director on 5 SEC Form D filings by 1 issuer between Oct 2021 and Jan 2026: BiomX Inc. (Ness Ziona, Israel (as filed: L3) — pharmaceuticals — 2021–2026; $61.5M reported sold to 34 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jonathan Solomon (5 shared filings), Marina Wolfson (5 shared filings), Merav Bassan (5 shared filings), Russell Greig (5 shared filings), Lynne Sullivan (3 shared filings) and 12 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Alan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Alan Moses and found 4 differences: Form D filed 17 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.